Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117201945 | 11720194 | 5 | F | 20160908 | 20151110 | 20160909 | EXP | CA-ROCHE-1626109 | ROCHE | 84.00 | YR | M | Y | 0.00000 | 20160909 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117201945 | 11720194 | 1 | PS | Rituximab | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | 103705 | 682.5 | MG | SOLUTION FOR INFUSION | |||||||
| 117201945 | 11720194 | 2 | SS | Rituximab | RITUXIMAB | 1 | U | 103705 | |||||||||||
| 117201945 | 11720194 | 3 | SS | BENDAMUSTINE HYDROCHLORIDE. | BENDAMUSTINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | U | 0 | 110 | MG | ||||||||
| 117201945 | 11720194 | 4 | SS | BENDAMUSTINE HYDROCHLORIDE. | BENDAMUSTINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | U | 0 | 163.8 | MG | ||||||||
| 117201945 | 11720194 | 5 | SS | Idelalisib | IDELALISIB | 1 | Oral | U | 0 | BID | |||||||||
| 117201945 | 11720194 | 6 | SS | Idelalisib | IDELALISIB | 1 | Oral | U | 0 | BID | |||||||||
| 117201945 | 11720194 | 7 | SS | NEULASTA | PEGFILGRASTIM | 1 | Subcutaneous | U | 0 | 6 | MG | ||||||||
| 117201945 | 11720194 | 8 | SS | NEULASTA | PEGFILGRASTIM | 1 | U | 0 | |||||||||||
| 117201945 | 11720194 | 9 | C | IMODIUM | LOPERAMIDE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 117201945 | 11720194 | 10 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 0 | TABLET | ||||||||||
| 117201945 | 11720194 | 11 | C | AMLODIPINE BESILATE | AMLODIPINE BESYLATE | 1 | Unknown | THERAPY DURATION 14 YEARS | 0 | ||||||||||
| 117201945 | 11720194 | 12 | C | APIXABAN | APIXABAN | 1 | 0 | ||||||||||||
| 117201945 | 11720194 | 13 | C | APO-LEVOCARB | CARBIDOPALEVODOPA | 1 | Oral | 0 | TABLET | ||||||||||
| 117201945 | 11720194 | 14 | C | COLCHICINE. | COLCHICINE | 1 | 0 | ||||||||||||
| 117201945 | 11720194 | 15 | C | HYDROXYZINE | HYDROXYZINEHYDROXYZINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 117201945 | 11720194 | 16 | C | HYDROXYZINE HYDROCHLORIDE. | HYDROXYZINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 117201945 | 11720194 | 17 | C | IMODIUM | LOPERAMIDE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 117201945 | 11720194 | 18 | C | LASIX | FUROSEMIDE | 1 | 0 | ||||||||||||
| 117201945 | 11720194 | 19 | C | MAGNESIUM GLUCONATE | MAGNESIUM GLUCONATE | 1 | 0 | ||||||||||||
| 117201945 | 11720194 | 20 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | TABLET | ||||||||||
| 117201945 | 11720194 | 21 | C | SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | 1 | 0 | ||||||||||||
| 117201945 | 11720194 | 22 | C | STEMETIL | PROCHLORPERAZINE MALEATE | 1 | 0 | ||||||||||||
| 117201945 | 11720194 | 23 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 0 | ||||||||||||
| 117201945 | 11720194 | 24 | C | TYLENOL | ACETAMINOPHEN | 1 | 0 | ||||||||||||
| 117201945 | 11720194 | 25 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 117201945 | 11720194 | 26 | C | ARISTOCORT | TRIAMCINOLONE DIACETATE | 1 | 0 | ||||||||||||
| 117201945 | 11720194 | 27 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 117201945 | 11720194 | 28 | C | MAGNESIUM SULFATE. | MAGNESIUM SULFATE | 1 | 0 | ||||||||||||
| 117201945 | 11720194 | 29 | C | SULFAMETHOXAZOLE/TRIMETHOPRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | 0 | ||||||||||||
| 117201945 | 11720194 | 30 | C | VALTREX | VALACYCLOVIR HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 117201945 | 11720194 | 31 | C | MACROGOL | POLYETHYLENE GLYCOLS | 1 | 0 | ||||||||||||
| 117201945 | 11720194 | 32 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | THERAPY DURATION 28 DAYS | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117201945 | 11720194 | 1 | B-cell lymphoma |
| 117201945 | 11720194 | 2 | Non-Hodgkin's lymphoma |
| 117201945 | 11720194 | 3 | B-cell lymphoma |
| 117201945 | 11720194 | 4 | Non-Hodgkin's lymphoma |
| 117201945 | 11720194 | 5 | B-cell lymphoma |
| 117201945 | 11720194 | 6 | Non-Hodgkin's lymphoma |
| 117201945 | 11720194 | 7 | B-cell lymphoma |
| 117201945 | 11720194 | 8 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117201945 | 11720194 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117201945 | 11720194 | Activities of daily living impaired | |
| 117201945 | 11720194 | Asthenia | |
| 117201945 | 11720194 | Autonomic nervous system imbalance | |
| 117201945 | 11720194 | Decreased appetite | |
| 117201945 | 11720194 | Dehydration | |
| 117201945 | 11720194 | Diarrhoea | |
| 117201945 | 11720194 | Fall | |
| 117201945 | 11720194 | Fatigue | |
| 117201945 | 11720194 | Mixed dementia | |
| 117201945 | 11720194 | Mobility decreased | |
| 117201945 | 11720194 | Muscular weakness | |
| 117201945 | 11720194 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |